Peer-influenced content. Sources you trust. No registration required. This is HCN.
Healthline
Two phase 3 trials found upadacitinib increased scalp, eyebrow, and eyelash regrowth in adolescents and adults with severe alopecia areata. Longer-term safety, durability, and regulatory review remain important considerations.
Dermatology September 2nd 2026
News Medical
A multicenter cross-sectional study associated symptomatic uncomplicated diverticular disease with reduced microbial diversity and distinct taxonomic and predicted functional patterns. The findings remain hypothesis-generating and require validation in larger, longitudinal cohorts.
Family Medicine/General Practice September 2nd 2026
Medical News Today (MNT)
The FDA approved Moderna’s mFLUSIVA, the first mRNA influenza vaccine, for adults aged 50 and older. Availability is expected during the 2026–2027 respiratory virus season, with confirmatory evidence pending for adults 65 and older.
MDLinx
Dolly Parton reported overlooking personal health concerns while caring for her husband, illustrating how caregiving can delay attention to symptoms. No unifying diagnosis or cause of death was disclosed.
All Specialties September 2nd 2026
MD Newsline
A primary care physician describes combining nutrition counseling, individualized monitoring, and pharmacotherapy in obesity care. The interview offers a practice philosophy rather than comparative evidence supporting one treatment strategy.
Cardiology September 1st 2026